Uranium Royalty renews $54M (U.S.) ATM program

Executive Summary

• Uranium Royalty Corp. renewed its at‑the‑market (ATM) equity program, authorizing up to US $54 million of common shares to be sold at market prices at the company’s discretion.
• Proceeds are earmarked for acquiring additional uranium royalties, streams, physical uranium and related interests, as well as for general working capital.
• The ATM agreement runs until either $54 million in gross sales proceeds is reached or September 5 2027, whichever occurs first.

Key Details

• Program Size: Up to US $54 million (or CAD equivalent) of common shares may be issued under the ATM program.
• Agents/Syndicate: Led by BMO Capital Markets; includes Canaccord Genuity, H.C. Wainwright & Co. LLC, National Bank Financial, Paradigm Capital Inc., Raymond James, and TD Securities.
• Distribution Agreement Date: August 20, 2025.
• Use of Proceeds: Finance acquisition of additional uranium royalties, streams, physical uranium holdings, and for working capital purposes.
• Termination Conditions: Program ends when cumulative gross sales proceeds reach $54 million or on September 5 2027, whichever is earlier.
• Regulatory Filings: Effective upon filing a prospectus supplement to the short‑form base shelf prospectus (dated August 5, 2025) and U.S. Form F‑10 registration statement (filed July 18, 2025, amended August 6, 2025). Documents will be available on SEDAR+ and EDGAR.
• Sale Mechanics: Shares sold at prevailing market price on Toronto Stock Exchange, Nasdaq Capital Markets, or other applicable markets per NI 44‑102 shelf distribution rules.

Notable Quotes

(No direct quotes provided in the release.)